RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION. (12th June 2019) - Cazelles, C.; Belhadj, K.; Vellemans, H.; Camus, V.; Copi‐Bergman, C.; Veresezan, L.; Itti, E.; Becker, S.; Carvalho, M.; Dupuis, J.; Fabien, L.; Lemonnier, F.; et al.